Akero Therapeutics, Inc. (AKRO)

Akero Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	176.03	340.24	234.21	249.77	150.48	187.24
Short-Term Investments	561.79	402.84	315.8	101.68	37.78	81.15
Cash & Short-Term Investments	737.83	743.08	550.01	351.45	188.26	268.39
Cash Growth	2.87%	35.10%	56.50%	86.69%	-29.86%	96.77%
Prepaid Expenses	16.71	27.3	9.95	3.72	5.32	2.96
Total Current Assets	754.54	770.38	559.96	355.17	193.58	271.35
Property, Plant & Equipment	0.55	0.76	1.03	1.29	1.55	1.79
Long-Term Investments	250.49	54.75	19.28	-	-	-
Other Long-Term Assets	-	-	-	0.11	0.42	0.2
Total Assets	1,006	825.89	580.27	356.57	195.55	273.34
Accounts Payable	20.4	9.03	7.04	7.97	6.71	3.43
Accrued Expenses	26.38	30.1	11.57	10.79	18.22	9.39
Current Portion of Leases	0.32	0.29	0.52	0.33	0.21	0.29
Other Current Liabilities	0.56	0.34	-	-	-	-
Total Current Liabilities	47.65	39.75	19.13	19.08	25.13	13.11
Long-Term Debt	-	35.3	24.96	9.54	-	-
Long-Term Leases	0.29	0.53	0.82	1.08	1.31	1.52
Other Long-Term Liabilities	-	0.19	0.05	0.31	-	-
Total Liabilities	47.94	75.77	44.97	30.01	26.44	14.63
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	2,005	1,575	1,109	748.86	479.44	468.24
Retained Earnings	-1,049	-826.16	-574.1	-422.34	-310.3	-209.53
Comprehensive Income & Other	1.83	0.95	0.27	0.04	-0.03	-0
Total Common Equity	957.64	750.11	535.31	326.56	169.11	258.71
Shareholders' Equity	957.64	750.11	535.31	326.56	169.11	258.71
Total Liabilities & Equity	1,006	825.89	580.27	356.57	195.55	273.34
Total Debt	0.61	36.12	26.31	10.95	1.52	1.81
Net Cash (Debt)	987.71	761.71	542.99	340.5	186.74	266.58
Net Cash Growth	31.51%	40.28%	59.47%	82.34%	-29.95%	95.56%
Net Cash Per Share	12.62	11.35	10.33	8.73	5.36	8.47
Filing Date Shares Outstanding	82.32	79.62	56.3	46.97	35.01	34.77
Total Common Shares Outstanding	80.15	72.38	55.75	46.87	34.9	34.74
Working Capital	706.88	730.63	540.83	336.09	168.45	258.23
Book Value Per Share	11.95	10.36	9.60	6.97	4.85	7.45
Tangible Book Value	957.64	750.11	535.31	326.56	169.11	258.71
Tangible Book Value Per Share	11.95	10.36	9.60	6.97	4.85	7.45

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q